Compugen Ltd. (CGEN)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Compugen Ltd., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Compugen Ltd. (CGEN) has returned 39.22% so far this year and 45.89% over the past 12 months. Over the last ten years, CGEN has returned -9.31% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.

Based on dividend-adjusted daily data since Aug 11, 2000, CGEN's average daily return is +0.09%, while the average monthly return is +1.84%. At this rate, your investment would double in approximately 3.2 years.

Historically, 45% of months were positive and 55% were negative. The best month was Dec 2023 with a return of +198.8%, while the worst month was Nov 2008 at -58.9%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 9 months.

On a daily basis, CGEN closed higher 45% of trading days. The best single day was Dec 19, 2023 with a return of +174.0%, while the worst single day was Nov 5, 2008 at -30.7%.

Compugen Ltd. has an annualized alpha of 15.45%, beta of 0.95, and R² of 0.05 versus S&P 500 Index. Calculated based on daily prices since August 14, 2000.

• This stock participated in 176.42% of S&P 500 Index downside but only 159.51% of its upside — more exposed to losses than it benefited from rallies.
• R² of 0.05 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

CGEN ranks 64 for risk / return — better than 64% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.

The table below present risk-adjusted performance metrics for Compugen Ltd. (CGEN) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Compugen Ltd.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Compugen Ltd. was 97.90%, occurring on Nov 24, 2008. Recovery took 2953 trading sessions.

The current Compugen Ltd. drawdown is 89.05%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Compugen Ltd. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Compugen Ltd. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.